Shukra Pharmaceuticals Ltd. (SHUKRAPHAR)
Market Closed
10 Aug, 22:00
MSE MSE Primary ₹
40. 08
+1.04
+2.6639%
₹
14.48B Market Cap
262.38 P/E Ratio
0.04% Div Yield
1.51M Volume
0 Eps
₹ 39.04
Previous Close Want to track SHUKRAPHAR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
SHUKRAPHAR closed today higher at ₹40.08, an increase of 2.6639% from yesterday's close, completing a monthly increase of 39.5543% or ₹11.36. Over the past 12 months, SHUKRAPHAR stock lost -28.7973%.
SHUKRAPHAR pays dividends to its shareholders, with the most recent payment made on Oct 30, 2025. The next estimated payment will be in In 2 months on Oct 30, 2026 for a total of ₹0.01.
The last earnings report, released on May 29, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Shukra Pharmaceuticals Ltd. has completed 5 stock splits, with the recent split occurring on Mar 21, 2025.
The company's stock is traded on one exchange.
SHUKRAPHAR Chart
People also search for
Shukra Pharmaceuticals Ltd. (SHUKRAPHAR) FAQ
What is the stock price today?
The current price is ₹40.08.
On which exchange is it traded?
Shukra Pharmaceuticals Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is SHUKRAPHAR.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.04%.
What is its market cap?
As of today, the market cap is 14.48B.
Has Shukra Pharmaceuticals Ltd. ever had a stock split?
Shukra Pharmaceuticals Ltd. had 5 splits and the recent split was on Mar 21, 2025.
Shukra Pharmaceuticals Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | - CEO | MSE Exchange | INE551C01028 ISIN |
| India Country | 115 Employees | 12 Sep 2025 Last Dividend | 21 Mar 2025 Last Split | - IPO Date |
Shukra Pharmaceuticals Ltd. is a company engaged in the manufacturing and marketing of pharmaceutical products. It primarily focuses on producing a variety of therapeutics and healthcare solutions for both domestic and international markets. The company operates within the pharmaceutical industry, which involves the research, development, production, and distribution of medications. This sector is crucial for public health and directly impacts numerous related industries, including biotechnology and healthcare services. Shukra Pharmaceuticals Ltd. plays a vital role in providing essential medications, thereby contributing to the effectiveness and efficiency of healthcare systems worldwide. By adhering to high standards of safety and efficacy, the company supports advancements in medical treatments and healthcare outcomes. Its operations may include ensuring compliance with regulatory norms, maintaining quality control, and pursuing innovation in drug development. Overall, Shukra Pharmaceuticals Ltd. is integral to the pharmaceutical supply chain and plays a significant role in the healthcare ecosystem.
Contact Information
Address: Veer House
Phone: 91 79 2749 8515
